Caplin Point Laboratories Limited
NSE: CAPLIPOINT | Information Technology
Market Fundamentals
Stock Intelligence & News
Next rally hinges on 23,800 breakout, says Dharmesh Shah on Nifty outlook
The domestic equity market experienced a strong intraday recovery, with the Nifty rebounding sharply and experts suggesting a 'buy on dips' structure. Key support is identified at 23,100–23,200, with potential upside towards 24,400 by June 2026. The metals and pharma sectors show continued strength, with JSW Steel and Caplin Point highlighted as top picks.
Read Full Analysis →Stocks to buy or sell: Dharmesh Shah of ICICI Sec suggests buying Caplin Point shares on 18 May
Nifty 50 and Sensex fell sharply on May 18 due to rising crude oil prices and geopolitical tensions. The rupee reached a record low, with all major sector indices declining. Investor sentiment weakened amid ongoing macroeconomic pressures.
Read Full Analysis →Caplin Point Laboratories Limited
Caplin Point Laboratories Limited has informed the Exchange that Record date for the purpose of Dividend is 30-May-2026. |SUBJECT: Record Date
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Caplin Point Laboratories Limited
Caplin Point Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 14, 2026, declared Interim Dividend of Rs. 4 per equity share. |SUBJECT: Dividend
Read Full Analysis →Caplin Point Laboratories Limited
Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. |SUBJECT: Outcome of Board Meeting
Read Full Analysis →Caplin Point Laboratories Limited
Financial Results/Dividend |Meeting Date: 14-May-2026
Read Full Analysis →Caplin Point Laboratories Limited
Board Meeting Intimation |Meeting Date: 14-May-2026
Read Full Analysis →Caplin Point Laboratories Limited
Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated May 05, 2026, titled "Receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for Calcium Gluconate Injection USP". |SUBJECT: Press Release
Read Full Analysis →Caplin Point Laboratories Limited
Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated March 13, 2026, titled "Receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for the Potassium Phosphates Injection USP". |SUBJECT: Press Release
Read Full Analysis →Caplin Point Laboratories Limited
Caplin Point Laboratories Limited has informed the Exchange regarding Cessation of Dr. C K Gariyali as Non- Executive Independent Director of the company w.e.f. March 03, 2026. |SUBJECT: Cessation
Read Full Analysis →Get instant alerts when CAPLIPOINT breaks news
Join investors who track Caplin Point Laboratories Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for CAPLIPOINT?
CAPLIPOINT is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Caplin Point Laboratories Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding CAPLIPOINT to your custom watchlist.